Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | MMP12 | P39900 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 1/20 | 0.38 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.38 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | NAMPT | P43490 | 1/20 | 0.36 |
| ▸ | CETP | P11597 | 1/20 | 0.36 |
| ▸ | VNN1 | O95497 | 1/20 | 0.35 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.35 |
| ▸ | TGM2 | P21980 | 1/20 | 0.35 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.35 |
| ▸ | CDC25B | P30305 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13817518 | 1.00 | FFAR1 (0.40) | FFAR1MMP1MMP12PRKCAPRKCD | |
| SCHEMBL13817524 | 0.94 | FFAR1 (0.40) | FFAR1MMP1MMP12PRKCAPRKCD | |
| SCHEMBL3106204 | 0.94 | FFAR1 (0.40) | FFAR1MMP1MMP12PRKCAPRKCD | |
| SCHEMBL3103154 | 0.92 | CYP19A1 (0.41) | FFAR1MMP1MMP12PRKCAPRKCD | |
| SCHEMBL13817467 | 0.92 | CYP19A1 (0.41) | FFAR1MMP1MMP12PRKCAPRKCD | |
| SCHEMBL3109506 | 0.91 | FFAR1 (0.43) | FFAR1MMP1MMP12PRKCAPRKCD | |
| SCHEMBL13817466 | 0.91 | FFAR1 (0.43) | FFAR1MMP1MMP12PRKCAPRKCD | |
| SCHEMBL3104050 | 0.91 | ALDH1A1 (0.41) | FFAR1MMP1MMP12PRKCAPRKCD | |
| SCHEMBL13817522 | 0.91 | ALDH1A1 (0.41) | FFAR1MMP1MMP12PRKCAPRKCD | |
| SCHEMBL13817519 | 0.90 | FFAR1 (0.40) | FFAR1MMP1MMP12PRKCAPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100273649-A1 | Fungicidal Mixtures III | BASF SE (DE) | 2010-10-28 | — | — | US | claimed |
| EP-2219459-A2 | FUNGICIDAL MIXTURES III | BASF SE (DE) | 2010-08-25 | — | — | EP | claimed |
| WO-2009063076-A2 | FUNGICIDAL MIXTURES III | BASF SE (DE) | 2009-05-22 | — | — | WO | claimed |
| US-20100273649-A1 | Fungicidal Mixtures III | BASF SE (DE) | 2010-10-28 | — | — | US | disclosed |
| EP-2219459-A2 | FUNGICIDAL MIXTURES III | BASF SE (DE) | 2010-08-25 | — | — | EP | disclosed |
| WO-2009063076-A2 | FUNGICIDAL MIXTURES III | BASF SE (DE) | 2009-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100273649-A1 | Fungicidal Mixtures III | CBR3, CBR1, NOX3 | FFAR1 421/4885MMP1 361/4885MMP12 1144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.